GlobeNewswire: The Arcview Group Contains the last 10 of 18 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T09:26:12ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2021/11/17/2336489/0/en/Evolving-the-Way-the-Business-of-Cannabis-Is-Done.html?f=22&fvtc=4&fvtv=41482Evolving the Way the Business of Cannabis Is Done2021-11-17T14:00:00Z<![CDATA[The Arcview Group Expands Reach of Collective Forces with Three New Strategic Alliance Partners The Arcview Group Expands Reach of Collective Forces with Three New Strategic Alliance Partners]]>https://www.globenewswire.com/news-release/2019/04/09/1799931/0/en/NEW-REPORT-Canadian-Legal-Cannabis-Market-Projected-to-Reach-5-2-Billion-by-2024.html?f=22&fvtc=4&fvtv=41482NEW REPORT: Canadian Legal Cannabis Market Projected to Reach $5.2 Billion by 20242019-04-09T16:21:40Z<![CDATA[Arcview Market Research and BDS Analytics release First-ever province-by-province analysis of Canadian cannabis market Arcview Market Research and BDS Analytics release First-ever province-by-province analysis of Canadian cannabis market]]>In our latest report, we bring you detailed provincial-level forecasts of the Canadian market and show the expected impact of the varying regulatory regimes being adopted by provinces.
The 40+ page report is available for $297 or as part of the Cannabis Intelligence Briefing Series subscription service from Arcview Market Research and BDS Analytics for $1,975.https://www.globenewswire.com/news-release/2019/02/26/1742819/0/en/New-Report-Signals-Coming-Competition-Between-Pharmaceutical-and-Cannabis-Industry.html?f=22&fvtc=4&fvtv=41482New Report Signals Coming Competition Between Pharmaceutical and Cannabis Industry2019-02-26T19:10:00Z<![CDATA[Oakland, California, Feb. 26, 2019 (GLOBE NEWSWIRE) -- A new report from Arcview Market Research (“Arcview Group”) and BDS Analytics details the many ways in which the cannabis industry could potentially disrupt the pharmaceutical industry. Entitled “Pharmacies vs. Dispensaries: The Future of Cannabinoids as Medicine,” the report explains that the pharmaceutical industry stands to be changed by the popularization of cannabis in two ways: the emergence of cannabis-derived pharmaceutical drugs, and the possible competition between pharmacies and dispensaries as customers begin to trust cannabis to alleviate health issues.“A slow pace of change is typical of the pharmaceutical industry, but medical cannabis could change that,” said Troy Dayton, CEO of the Arcview Group. “It was the medical cannabis industry that initially provided CBD-based relief to children with epileptic seizures, and is currently helping thousands of patients who are suffering from a vast array of other conditions. Now, the pharmaceutical industry is slowly emerging from 80 years of prohibition-induced neglect towards the potential of cannabis-plant medicines.”The report indicates that cannabinoid pharmaceutical sales are unlikely to take off in the near term, as only five cannabinoid-based pharmaceuticals are in third-stage trials, and therefore have a chance of getting through the FDA approval process and onto the market before 2022. That said, sales of all cannabis-based pharmaceuticals are projected to make up 10% of the $31.6-billion legal cannabis market by 2022. “Epidiolex and the pipeline of pharmaceuticals behind it set up a whole new competitive dynamic,” said Tom Adams, editor in chief of Arcview Market Research and managing director of BDS Analytics Industry Intelligence, which collaborated on the report. “For the first time, cannabis dispensaries will face pharmaceutical competition with its FDA imprimatur and the potential advantage of insurance subsidization. But at the same time, the pharmaceutical industry is not used to competing with stores selling effectively the same product it offers at a much lower price.”Other key factors analyzed in the Pharmacies vs. Dispensaries: The Future of Cannabinoids as Medicine include:]]>Now Out: Pharmacies vs. Dispensaries: The Future of Cannabinoids as Medicine
The nearly 60-page report is available for $297 or as part of the Cannabis Intelligence Briefing Series subscription service from Arcview Market Research and BDS Analytics for $1,975.https://www.globenewswire.com/news-release/2019/01/15/1691880/0/en/NEW-REPORT-Worldwide-Legal-Cannabis-Spending-Hits-12-2-Billion-in-2018-projected-to-Grow-38-to-16-9-Billion-in-2019.html?f=22&fvtc=4&fvtv=41482NEW REPORT: Worldwide Legal Cannabis Spending Hits $12.2 Billion in 2018, projected to Grow 38% to $16.9 Billion in 20192019-01-15T16:30:00Z<![CDATA[Oakland, California, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Worldwide consumer spending on legal cannabis is expected to reach an estimated $12.2 billion in 2018, a significant jump from $9.5 billion in 2017, according to the “2019 Update to The State of Legal Marijuana Markets” (SOLMM) report released today from Arcview Market Research (“Arcview Group”) and BDS Analytics.The 28% worldwide growth estimated for 2018 is slightly behind the growth rate forecast made in the original SOLMM report released in June, as Canada delayed the launch of its program from June to October and California’s expensive tax and regulatory structure hobbled legal operators in their competition with the state’s robust illicit trade. Arcview Market Research now forecasts that spending growth will accelerate in 2019, jumping 38% to $16.9 billion, and going on to reach $31.3 billion in 2022, growing at a 26.7% compound annual growth rate (CAGR) over the five-year frame from 2017.]]>https://www.globenewswire.com/news-release/2018/09/21/1574365/0/en/Arcview-Co-Hosts-Hong-Kong-s-First-Ever-Cannabis-Investor-Symposium.html?f=22&fvtc=4&fvtv=41482Arcview Co-Hosts Hong Kong's First Ever Cannabis Investor Symposium2018-09-21T14:00:00Z<![CDATA[Legal Cannabis Business Expected to Generate $57 Billion Globally by 2027 Legal Cannabis Business Expected to Generate $57 Billion Globally by 2027]]>The Arcview Group co-hosts Hong Kong’s first ever Cannabis Investor Symposium, bringing together industry leaders & the investment community on Nov. 1, 2018 at the W Hotel. In partnership with CannaTech and URI Capital Management. Register now!https://www.globenewswire.com/news-release/2018/09/11/1569444/0/en/Cannabis-Entrepreneurs-Pitch-Private-Investors-In-Chicago-September-16-18.html?f=22&fvtc=4&fvtv=41482Cannabis Entrepreneurs Pitch Private Investors In Chicago September 16 - 182018-09-11T21:18:12Z<![CDATA[MedMen’s Adam Bierman and Cowen’s Vivien Azer to address group;Promising Cannabis Companies Pitch Investors in ‘Shark-Tank’ Style Format MedMen’s Adam Bierman and Cowen’s Vivien Azer to address group;Promising Cannabis Companies Pitch Investors in ‘Shark-Tank’ Style Format]]>https://www.globenewswire.com/news-release/2018/07/12/1536823/0/en/Marijuana-Entrepreneurs-Pitch-Private-Investors-In-San-Francisco-July-19-21.html?f=22&fvtc=4&fvtv=41482Marijuana Entrepreneurs Pitch Private Investors In San Francisco July 19 - 212018-07-12T19:37:03Z<![CDATA[Former RNC Chair Michael Steele to Address Group; Dozens of Promising Cannabis Companies Pitch Investors in ‘Shark-Tank’ Style Format Former RNC Chair Michael Steele to Address Group; Dozens of Promising Cannabis Companies Pitch Investors in ‘Shark-Tank’ Style Format]]>https://www.globenewswire.com/news-release/2018/06/28/1531033/0/en/NEW-REPORT-Legal-Marijuana-Markets-Projected-to-Reach-23-4-Billion-Employ-Nearly-a-Half-Million-Americans-by-2022-Effective-End-of-Federal-Prohibition-is-in-Sight.html?f=22&fvtc=4&fvtv=41482NEW REPORT: Legal Marijuana Markets Projected to Reach $23.4 Billion, Employ Nearly a Half-Million Americans by 2022; Effective End of Federal Prohibition is in Sight2018-06-28T13:00:00Z<![CDATA[The State of Legal Marijuana Markets, Sixth Edition assesses the global economics, politics, and consumer trends of the cannabis industry The State of Legal Marijuana Markets, Sixth Edition assesses the global economics, politics, and consumer trends of the cannabis industry]]>https://www.globenewswire.com/news-release/2018/06/26/1529947/0/en/Exclusive-Interview-Former-RNC-Chair-Michael-Steele-Speaks-His-Mind-on-Marijuana-Legalization-and-More.html?f=22&fvtc=4&fvtv=41482Exclusive Interview: Former RNC Chair Michael Steele Speaks His Mind on Marijuana Legalization and More2018-06-26T20:01:39Z<![CDATA[Steele: “The war on drugs as a political concept and a social response has failed. In fact, it has probably done more to make drug addictions worse.” Steele: “The war on drugs as a political concept and a social response has failed. In fact, it has probably done more to make drug addictions worse.”]]>https://www.globenewswire.com/news-release/2018/04/19/1482048/0/en/Marijuana-Companies-Investors-from-the-U-S-and-Canada-Plot-Next-Moves-In-Vancouver-April-30-May-2.html?f=22&fvtc=4&fvtv=41482Marijuana Companies & Investors from the U.S. and Canada Plot Next Moves In Vancouver April 30 - May 22018-04-19T16:49:10Z<![CDATA[1st NASDAQ-traded company CEO, Mike Gorenstein of Cronos Group and most pro-cannabis Republican, Congressman Dana Rohrabacher to address group; Dozens of Promising Cannabis Companies Pitch Investors in ‘Shark-Tank’ Style Format 1st NASDAQ-traded company CEO, Mike Gorenstein of Cronos Group and most pro-cannabis Republican, Congressman Dana Rohrabacher to address group; Dozens of Promising Cannabis Companies Pitch Investors in ‘Shark-Tank’ Style Format]]>